enGene Holdings Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
enGene Holdings Inc
CIK #0001980845
EDGAR Form CIK 2011 - 2026
10-K [0001980845]
10-Q [0001980845]
3 [0001980845]
4 [0001980845]
8-K [0001980845]
SC 13D [0001980845]
SC 13G [0001980845]
Form 13D/13G Filer Form 13D/13G Subject Filed
BML Investment Partners LP Engene Therapeutics Inc [2026-05-13]
Cormorant Asset Management LP Engene Holdings Inc [2026-02-17]
Invus Global Management LLC Engene Holdings Inc [2026-01-27]
Perceptive Advisors LLC Engene Holdings Inc [2025-11-18]
Deep Track Capital LP Engene Holdings Inc [2025-11-18]
Kynam Capital Management LP Engene Holdings Inc [2025-02-14]
Adage Capital Management LP Engene Holdings Inc [2024-11-12]
Venrock Healthcare Capital Partners III LP Engene Holdings Inc [2024-02-26]
Foresite Capital Fund VI LP Engene Holdings Inc [2024-02-23]
Deep Track Capital LP Engene Holdings Inc [2024-02-23]
View All
Form 3/4/5 Subject 2011 - 2026
enGene Therapeutics Inc
Zoth Lota S
Astley-Sparke Philip
Brunk Gerald A
Glickman Richard M
Grossman William
Hastings Paul J
Heffernan Michael Thomas
Joustra Wouter
Boyd Matthew Ross
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 220,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 801,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2026-01-30 Grant 195,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-09-30 Grant 600,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-07-08 Grant 100,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-07-08 Grant 45,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-07-08 Grant 45,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-07-08 Grant 45,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-07-08 Grant 100,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 22,500 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 400,000 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 22,500 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 22,500 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 22,500 $0.00
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
2025-06-16 Grant 22,500 $0.00
showing 20 of 110 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com